Tivic Health Systems, INC DEF 14A proxy statements

Valion Bio, Inc. is holding a special meeting on August 14, 2026, to seek stockholder approval for a reverse stock split aimed at maintaining its Nasdaq listing.

Valion Bio, Inc. has issued its definitive proxy statement detailing proposals for its 2026 Annual Meeting of Stockholders, including director elections, equity plan amendments, and ratification of its accounting firm.

Tivic Health Systems, Inc. calls a special meeting to approve significant common stock issuances tied to convertible preferred stock, a secured note, and warrants, crucial for future funding and a recent acquisition.

Tivic Health Systems, Inc. is calling its stockholders to a virtual annual meeting on June 30, 2025, to vote on critical proposals including a significant increase in its equity incentive plan, and the issuance of common stock tied to recent strategic license agreements and substantial capital funding initiatives.

Tivic Health Systems is asking stockholders to approve a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.

Tivic Health Systems has filed a definitive proxy statement with the SEC, signaling preparations for an upcoming shareholder meeting.

Tivic Health Systems announces its 2024 Annual Meeting of Stockholders to be held virtually on August 9, 2024, featuring proposals for director elections, equity incentive plan amendments, and auditor ratification.